Cargando…
Febrile patients admitted to remote hospitals in Northeastern Kenya: seroprevalence, risk factors and a clinical prediction tool for Q-Fever
BACKGROUND: Q fever in Kenya is poorly reported and its surveillance is highly neglected. Standard empiric treatment for febrile patients admitted to hospitals is antimalarials or penicillin-based antibiotics, which have no activity against Coxiella burnetii. This study aimed to assess the seropreva...
Autores principales: | Njeru, J., Henning, K., Pletz, M. W., Heller, R., Forstner, C., Kariuki, S., Fèvre, E. M., Neubauer, H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4891891/ https://www.ncbi.nlm.nih.gov/pubmed/27260261 http://dx.doi.org/10.1186/s12879-016-1569-0 |
Ejemplares similares
-
Human Brucellosis in Febrile Patients Seeking Treatment at Remote Hospitals, Northeastern Kenya, 2014–2015
por: Njeru, John, et al.
Publicado: (2016) -
Serological evidence of Francisella tularensis in febrile patients seeking treatment at remote hospitals, northeastern Kenya, 2014–2015
por: Njeru, J., et al.
Publicado: (2017) -
Q fever is an old and neglected zoonotic disease in Kenya: a systematic review
por: Njeru, J., et al.
Publicado: (2016) -
Systematic review of brucellosis in Kenya: disease frequency in humans and animals and risk factors for human infection
por: Njeru, J., et al.
Publicado: (2016) -
High Seroprevalence of Antibodies against Spotted Fever and Scrub Typhus Bacteria in Patients with Febrile Illness, Kenya
por: Thiga, Jacqueline W., et al.
Publicado: (2015)